Research Matters
Groundbreaking innovations that begin in Stanford labs flow freely into private industry to improve human well-being, fuel the economy, and strengthen American competitiveness.

An antibody-based approach for Fanconi anemia replaces traditional toxic conditioning with targeted therapy, allowing safe restoration of blood and immune function without chemotherapy or radiation.
